BioConvergence LLC is expanding its Bloomington, IN headquarters in an effort to better serve its pharma/biopharmaceutical clients. BioConvergence will add approximately 20,000 sq. ft. to its existing 50,000-sq.-ft. facility to accommodate its growing cGMP materials management business unit. The expansion also adds approximately 15 new employees to its existing 21 employees and includes a multi-million dollar investment in facilities and equipment.
“BioConvergence began with a goal to serve growing life sciences businesses in need of an experienced partner for the development of new molecules heading to the clinic and market and to provide unsurpassed materials and supply chain management capabilities that are increasingly in demand across the world. Our clients have shown confidence in our ability to deliver valuable results with speed and quality. We have been audited by the FDA and have earned preferred provider status with multiple clients,” said Alisa Wright, chief executive officer of BioConvergence.
"The new expansion of our facility and our employment growth projections keep BioConvergence on track to fulfill commitments for incentives from the State of Indiana and Monroe County, and we thank our government, economic development, community and business partners for their past support, which have allowed us to get our business up to speed in our first year of operations. We look forward to many years of growth to come,” Ms. Wright added.
Magazine
